Further evaluation of the EORTC QLQ-C30 psychometric properties in a large Brazilian cancer patient cohort as a function of their educational status

Supportive Care in Cancer

Volumn 22, Issue 8, 2014, Pages 2151-2160

  Paiva, Carlos Eduardo ^a,b   Carneseca, Estela Cristina ^a   Barroso, Eliane Marçon ^a   De Camargos, Mayara Goulart ^a   Alfano, Ana Camila Callado ^a   Rugno, Fernanda Capella ^a   Paiva, Bianca Sakamoto Ribeiro ^a  

^a BARRETOS CANCER HOSPITAL   (Brazil)

^b Departamento de Oncologia Clínica   (Brazil)

Author keywords

Cancer; EORTC QLQ C30; Health related quality of life; Reliability; Validation

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BRAZIL; BREAST; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; COGNITION; CONTROLLED STUDY; CONVERGENT VALIDITY; EDMONTON SYMPTOM ASSESSMENT SYSTEM; EDUCATIONAL STATUS; EMOTIONALITY; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER CORE QUALITY OF LIFE 30; FATIGUE; FEMALE; FEMALE GENITAL SYSTEM; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTESTINE; LUNG; MALE; MALIGNANT NEOPLASTIC DISEASE; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NAUSEA AND VOMITING; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSTATE; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL INTERACTION; UPPER GASTROINTESTINAL TRACT; UROGENITAL SYSTEM; WHOQOL BREF;

ADULT; AGED; BRAZIL; COHORT STUDIES; EDUCATIONAL STATUS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 84905117134     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-014-2206-3     Document Type: Article

References (38)

1. Osoba D (1994) Lessons learned from measuring health-related quality of life in oncology. J Clin Oncol 12(3):608-616
2. Cella DF (1994) Quality of life: concepts and definition. J Pain Symptom Manag 9(3):186-192
3. Basch E, Abernethy AP, Mullins CD, Reeve BB, Smith ML, Coons SJ et al (2012) Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. J Clin Oncol 30(34):4249-4255
4. Bottomley A, Quinten C, Coens C, Martinelli F, Mauer M, Maringwa J et al (2009) Making better use of existing cancer data: patient reported outcomes and behavioural evidence: a new international initiative. Eur J Cancer Care (Engl) 18(2):105-107
5. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365-376 (Pubitemid 23073154)
6. Cankurtaran ES, Ozalp E, Soygur H, Ozer S, Akbiyik DI, Bottomley A (2008) Understanding the reliability and validity of the EORTC QLQC30 in Turkish cancer patients. Eur J Cancer Care (Engl) 17(1):98-104
7. Franceschini J, Jardim JR, Fernandes AL, Jamnik S, Santoro IL (2010) Reproducibility of the Brazilian Portuguese version of the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire used in conjunction with its lung cancer-specific module. J Bras Pneumol 36(5):595-602
8. (EORTC) EORTC QLQ-C30. http://groups.eortc.be/qol/eortc-qlq-c30. Accessed 08/05/2013
9. Brabo EP, Paschoal ME, Biasoli I, Nogueira FE, Gomes MC, Gomes IP, Martins LC, Spector N (2006) Brazilian version of the QLQ-LC13 lung cancer module of the European Organization for Research and Treatment of Cancer: preliminary reliability and validity report. Qual Life Res 15(9):1519-1524 (Pubitemid 44736784)
10. Hahn EA, Rao D, Cella D, Choi SW (2008) Comparability of interview- and self-administration of the functional assessment of cancer therapy-general (FACT-G) in English- and Spanish-speaking ambulatory cancer patients. Med Care 46(4):423-431
11. Botega NJ, Pondé MP, Medeiros P, Lima MG, Guerreiro CAM (1998) Validação da escala hospitalar de ansiedade e depressão (HAD) em pacientes epilépticos ambulatoriais. J Bras Psiquiatr 47(6):285-289 (Pubitemid 128530063)
12. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7(2):6-9
13. Cheung WY, Barmala N, Zarinehbaf S, Rodin G, Le LW, Zimmermann C (2009) The association of physical and psychological symptom burden with time to death among palliative cancer outpatients. J Pain Symptom Manag 37(3):297-304
14. Fleck MP, Louzada S, Xavier M, Chachamovich E, Vieira G, Santos L, Pinzon V (2000) Application of the Portuguese version of the abbreviated instrument of quality life WHOQOL-bref. Rev Saude Publica 34(2):178-183
15. Ma C, Bandukwala S, Burman D, Bryson J, Seccareccia D, Banerjee S, Myers J, Rodin G, Dudgeon D, Zimmermman C (2010) Interconversion of threemeasures of performance status: an empirical analysis. Eur J Cancer 46(18):3175-3183
16. Fayers P, Machin D (2007) Quality of life: the assessment, analysis and interpretation of patient-reported outcomes. Wiley, UK
17. Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, Bouter LM, de Vet HC (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60(1):34-42 (Pubitemid 44856236)
18. Ware JE, Harris WJ, Gandek B, Rogers BW, Reese PR (1997) MAP-R for windows: multitrait multi-item analysis program - revised user's guide. Health Assessment Lab, Boston
19. Osoba D, Rodrigues G, Myles J, Zee B, Pater J (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16(1):139-144 (Pubitemid 28041591)
20. da Educação M (2003) Sistema nacional de avaliação da educação básica.Qualidade da educação: Uma nova leitura do desempenho dos estudantes da oitava série do ensino fundamental. Ministério da Educação, Brasília
21. Ringdal GI, Ringdal K (1993) Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnoses. Qual Life Res 2(2):129-140 (Pubitemid 23135397)
22. Kontodimopoulos N, Samartzis A, Papadopoulos AA, Niakas D (2012) Reliability and validity of the Greek QLQ-C30 and QLQ-MY20 for measuring quality of life in patients with multiple myeloma. TheScientificWorldJournal:842867
23. Awad MA, Denic S, El Taji H (2008) Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaires for Arabic-speaking populations. Ann N YAcad Sci 1138:146-154
24. Huijer HA, Sagherian K, Tamim H (2013) Validation of the Arabic version of the EORTC quality of life questionnaire among cancer patients in Lebanon. Qual Life Res 22(6):1473-1481
25. Luo N, Fones CS, Lim SE, Xie F, Thumboo J, Li SC (2005) The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-c30): validation of English version in Singapore. Qual Life Res 14(4):1181-1186 (Pubitemid 40685240)
26. Cerezo O, Onate-Ocana LF, Arrieta-Joffe P, Gonzalez-Lara F, Garcia-Pasquel MJ, Bargallo-Rocha E, Vilar-Compte D (2012) Validation of the Mexican-Spanish version of the EORTC QLQ-C30 and BR23 questionnaires to assess health-related quality of life in Mexican women with breast cancer. Eur J Cancer Care (Engl) 21(5):684-691
27. Hoopman R, Muller MJ, Terwee CB, Aaronson NK (2006) Translation and validation of the EORTC QLQ-C30 for use among Turkish and Moroccan ethnic minority cancer patients in the Netherlands. Eur J Cancer 42(12):1839-1847 (Pubitemid 44149081)
28. Huang CC, Lien HH, Sung YC, Liu HT, Chie WC (2007) Quality of life of patients with gastric cancer in Taiwan: validation and clinical application of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-STO22. Psychooncology 16(10):945-949
29. Wan C, Meng Q, Yang Z, Tu X, Feng C, Tang X, Zhang C (2008) Validation of the simplified Chinese version of EORTC QLQ-C30 from the measurements of five types of inpatients with cancer. Ann Oncol 19(12):2053-2060
30. Nicklasson M, Bergman B (2007) Validity, reliability and clinical relevance of EORTC QLQ-C30 and LC13 in patients with chest malignancies in a palliative setting. Qual Life Res 16(6):1019-1028 (Pubitemid 47174894)
31. Silpakit C, Sirilerttrakul S, Jirajarus M, Sirisinha T, Sirachainan E, Ratanatharathorn V (2006) The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): validation study of the Thai version. Qual Life Res 15(1):167-172 (Pubitemid 43097597)
32. Silveira A, Goncalves J, Sequeira T, Ribeiro C, Lopes C, Monteiro E, Pimentel FL (2001) [Computer-based quality-of-life monitoring in head and neck cancer patients: a validation model using the EORTCQLQ C30 and EORTC- H&N35 Portuguese PC-software version]. Acta Med Port 24(Suppl 2):347-354
33. Safaee A, Moghim Dehkordi B (2007) Validation study of a quality of life (QOL) questionnaire for use in Iran. Asian Pac J Cancer Prev 8(4):543-546
34. Apolone G, Filiberti A, Cifani S, Ruggiata R, Mosconi P (1998) Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 health survey in a cohort of Italian long-survival cancer patients. Ann Oncol 9(5):549-557 (Pubitemid 28270644)
35. Perwitasari DA, Atthobari J, Dwiprahasto I, Hakimi M, Gelderblom H, Putter H, Nortier JW, Guchelaar HJ, Kaptein HA (2011) Translation and validation of EORTC QLQ-C30 into Indonesian version for cancer patients in Indonesia. Jpn J Clin Oncol 41(4):519-529
36. Chie WC, Chang KJ, Huang CS, Kuo WH (2003) Quality of life of breast cancer patients in Taiwan: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-BR23. Psychooncology 12(7):729-735
37. Chie WC, Hong RL, Lai CC, Ting LL, Hsu MM (2003) Quality of life in patients of nasopharyngeal carcinoma: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and the EORTC QLQ-H&N35. Qual Life Res 12(1):93-98
38. Kuenstner S, Langelotz C, Budach V, Possinger K, Krause B, Sezer O (2002) The comparability of quality of life scores. A multitrait multimethod analysis of the EORTC QLQ-C30, SF-36 and FLIC questionnaires. Eur J Cancer 38(3):339-348 (Pubitemid 34121961)